Search

Search Constraints

You searched for: Author/Creator Uenami, Takeshi

Search Results

3. Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report. Issue 5 (9th April 2019)

5. Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report. Issue 12 (11th May 2021)

7. Hyperprogressive disease in patients with non‐small cell lung cancer treated with nivolumab: A case series. Issue 12 (17th October 2018)

8. Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis. Issue 11 (14th September 2019)

9. Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT). (December 2021)

10. Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON). (November 2021)